FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke
Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular…
Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of the once-daily pill covers secondary stroke prevention in adults. The post FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke appeared first on MedCity News.
Goal is to provide stable and predictable revenue while encouraging more preventive and coordinated care
This policy watch examines what the 2026 Midterm Election results and Democratic control of Congress might mean for global health.
Higher-level reviews identified more than 329,000 medical evidence-collection errors in fiscal year 2026
Healthcare has plenty of tedious administrative work which could benefit from AI’s efficiency – but what if simply speeding up an already broken system isn’t the answer? Healthcare leaders push for a re-built, AI-native system in Anterior’s recent Beyond Faster Horses campaign. The post New Campaign Wants AI Applications To Look Beyond Speed appeared first…
The industry’s next major competitor may never build another national laboratory network or employ thousands of phlebotomists. It may simply own the device that notices something first. The post The Laboratory Industry’s Next Competitor May Be the Company on Your Patient’s Wrist appeared first on MedCity News.
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” He was 72, a retired health administrator who lived alone near Seattle. Laura Prater, a firearms researcher at Ohio State, was interviewing him via Zoom. She’d administered a questionnaire that…
(Maria Fabrizio for WPLN and KFF Health News) Not many 22-year-olds share DJ Mikunda’s enthusiasm for health insurance coverage. “You know what sounds like a good Friday night? It’s looking at health insurance,” he joked. But Mikunda has a reason to be eager. He has gone without coverage since he left home and started working…
Eli McCreary of Omaha, Nebraska, said he had recently been diagnosed with kidney cancer when he got a call from a local hospital run by CHI Health. He said he was informed that he wasn’t insured anymore under Medicaid — and that the hospital would cancel his appointments unless he paid out-of-pocket. McCreary, who was…
AI is speeding up the search for new medicines. Can it make the discoveries themselves? Few people are better placed to answer than Dr. Elias Zerhouni. He ran the National Institutes of Health, then global R&D at Sanofi. He co-founded ModeX Therapeutics, which uses machine learning to design antibodies that don’t exist in nature, and…